Company profile: Modulim
1.1 - Company Overview
Company description
- Provider of light-based imaging and care management solutions: Clarifi Imaging System, a non-contact, noninvasive tool using spatial frequency domain imaging to assess microvascular health by measuring tissue oxygenation and perfusion; LAMP, integrating patient assessment, data management, and care coordination; Modulim Cloud, a HIPAA-compliant platform for secure data and imaging; and Magnifi Software for tailored views and remote care collaboration.
Products and services
- Clarifi Imaging System: A noninvasive, non-contact instrument employing spatial frequency domain imaging to assess microvascular health by measuring tissue oxygenation and perfusion
- Modulim Cloud: A HIPAA-compliant platform for secure storage, sharing, and management of patient data and imaging, supporting clinical decision-making
- LAMP: An integrated system combining patient assessment, data management, and care coordination that utilizes Clarifi imaging and Modulim Cloud for efficient patient care
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Modulim
Sano
HQ: United States
Website
- Description: Provider of a small wearable sensor that continuously captures and transmits blood chemistry data to virtually any device and liberates this data to a third-party development and analytical platform called the 'API for the bloodstream'.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sano company profile →
Sensulin
HQ: United States
Website
- Description: Provider of diabetes drug discovery focused on a once-a-day glucose-responsive insulin for type 1 and type 2 diabetes, designed to reduce hypoglycemia risk and long-term complications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sensulin company profile →
CureDM
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies that may prevent, ameliorate or reverse diabetes, including Human proIslet Peptide (HIP), a novel human peptide developed to regenerate insulin-producing islets in the pancreas and potentially restore pancreatic function without stem cells, with the goal of allowing discontinuation of insulin.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CureDM company profile →
TheracosBio
HQ: United States
Website
- Description: Provider of Brenzavvy, an FDA-approved oral treatment for type 2 diabetes, with a focus on accessible medications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TheracosBio company profile →
Medicore
HQ: United States
Website
- Description: Provider of blood collection and diabetic care products, manufacturing and distributing to hospitals and medical companies. Holds multiple contracts with hospital group purchasing organizations, with product line available through nearly all major medical device distributors.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medicore company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Modulim
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Modulim
2.2 - Growth funds investing in similar companies to Modulim
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Modulim
4.2 - Public trading comparable groups for Modulim
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →